Drug Database
Back to search

Belgium· BE-AMP-SAM209133-00

AmoclaneEG 500 mg - 125 mg

A amoxicillin und beta-lactamase-inhibitor product containing potassium clavulanate, registered in Belgium by EG. The same ATC class is registered in 13 of our 19 countries.

ATC J01CR02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAmoclaneEG 500 mg - 125 mgATCJ01CR02REGISTER NO.BE-AMP-SAM209133-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about potassium clavulanateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Amoxicillin und beta-lactamase-inhibitor is registered in 13 of 19 countries.

Countries holding a registration under ATC J01CR02 (amoxicillin und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search amoxicillin und beta-lactamase-inhibitor products by name

Amoxicillin und beta-lactamase-inhibitor · ATC J01CR02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of amoxicillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.28 in Italy to $5.60 in Switzerland — a ×4.4 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Amoxicillin und beta-lactamase-inhibitor · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.60
  • ES Spain$4.65
  • CZ Czechia$1.42
  • IT Italy$1.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Potassium Clavulanate
Manufacturer
EG
Country
Belgium (BE)
ATC code
J01CR02
ATC class
Amoxicillin und Beta-Lactamase-Inhibitor
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

2 priced
  • be_apb
    2622330
    EUR 11.18
  • be_apb
    2622355
    EUR 16.01
  • be_apb
    0794552

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for amoxicillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check amoxicillin und beta-lactamase-inhibitor against other medicinesHow interaction checks work

Amoxicillin und beta-lactamase-inhibitor · interactions on record

24 records

  • 4 severe
  • 17 moderate

Most severe, free to view

  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • TeriflunomideL04AK02severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01CR02

Amoxicillin und beta-lactamase-inhibitor, as other registers publish it.

All amoxicillin und beta-lactamase-inhibitor products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd681935-e232-492b-8c4f-0b6f4b143fae
GET /v1/drugs/cd681935-e232-492b-8c4f-0b6f4b143fae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "AmoclaneEG 500 mg - 125 mg",
  "name_fr": "AmoclaneEG 500 mg - 125 mg",
  "name_nl": "AmoclaneEG 500 mg - 125 mg",
  "amp_code": "SAM209133-00",
  "strengths": [
    "148.9000",
    "574.0000",
    "125.0000",
    "500.0000",
    "574.0000",
    "148.9000",
    "500.0000",
    "125.0000"
  ],
  "pack_count": 8,
  "substances": [
    "Potassium Clavulanate",
    "Amoxicillin Trihydrate",
    "Clavulanic Acid",
    "Amoxicillin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Amoxicillin and Beta-Lactamase Inhibitor",
  "authorisation_numbers": [
    "BE209133"
  ]
}
API referenceMCP serverPlans

See everything about amoxicillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console